Literature DB >> 17441316

Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y.

Hai-Xia Tong1, Chun-Wei Lu, Ji-Hong Zhang, Li Ma, Jin-Hua Zhang.   

Abstract

OBJECTIVE: To study the effect of gamma-interferon (IFNgamma), tumor necrosis factor related apoptosis inducing ligand (TRAIL), and cisplatin or etoposide induced apoptosis in human neuroblastoma cell line SH-SY5Y and its possible molecular mechanisms.
METHODS: The expressions of Caspase 8 mRNA and protein were detected with RT-PCR and Western blot analysis. The effects of IFN-gamma, TRAIL, IFNgamma + TRAIL, IFN-gamma + Caspase 8 inhibitor + TRAIL, IFNgamma + cisplatin + TRAIL, and IFNgamma + etoposide + TRAIL on the growth and apoptosis of SH-SY5Y cells were detected with the methods of MTT and flow cytometry. The relative Caspase 8 activity was measured with colorimetric assay.
RESULTS: Caspase 8 was undetectable in SH-SY5Y cells but an increased expression of Caspase 8 mRNA and protein was found after treatment with IFNgamma. SH-SY5Y cells themselves were not sensitive to TRAIL, but those expressing Caspase 8 after treatment with IFNgamma were. The killing effect of TRAIL on SH-SY5Y cells expressing Caspase 8 was depressed by Caspase 8 inhibitor. Cisplatin and etoposide could enhance the sensitivity of TRAIL on SH-SY5Y cells. The relative Caspase 8 activity of SH-SY5Y cells in IFN-gamma + TRAIL group was significantly higher than those of control group, IFN-gamma group, TRAIL group, and inhibitor group (P < 0.01). There was no significant difference among IFN-gamma + TRAIL group, IFNgamma + cisplatin + TRAIL group, and IFNgamma + etoposide + TRAIL group.
CONCLUSIONS: IFNgamma could sensitize SH-SY5Y cells to TRAIL-induced apoptosis and this may be realized by the up-regulation of Caspase 8. Cisplatin and etoposide could enhance the killing effect of TRAIL on SH-SY5Y cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17441316

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  5 in total

1.  Modulation of innate immune-related pathways in nicotine-treated SH-SY5Y cells.

Authors:  Wen-Yan Cui; Ju Wang; Jinxue Wei; Junran Cao; Sulie L Chang; Jun Gu; Ming D Li
Journal:  Amino Acids       Date:  2011-12-21       Impact factor: 3.520

2.  Neurogenic chronic intestinal pseudo-obstruction: antineuronal antibody-mediated activation of autophagy via Fas.

Authors:  Roberto de Giorgio; Umberto Volta; Vincenzo Stanghellini; Rosanna F Cogliandro; Giovanni Barbara; Roberto Corinaldesi; Roberto Towns; Chunfang Guo; Shuangsong Hong; John W Wiley
Journal:  Gastroenterology       Date:  2008-05-15       Impact factor: 22.682

3.  NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis.

Authors:  P Ruggeri; L Cappabianca; A R Farina; L Gneo; A R Mackay
Journal:  Cell Death Discov       Date:  2016-02-01

4.  TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.

Authors:  Luciana Gneo; Pierdomenico Ruggeri; Lucia Cappabianca; Antonietta Rosella Farina; Natalia Di Ianni; Andrew Reay Mackay
Journal:  Oncotarget       Date:  2016-12-06

5.  Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study.

Authors:  Lorenzo Anasagasti-Angulo; Yanelda Garcia-Vega; Silvia Barcelona-Perez; Pedro Lopez-Saura; Iraldo Bello-Rivero
Journal:  BMC Cancer       Date:  2009-07-30       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.